Helios India Rising PMS Review: Performance, Fees & Should You Stay Invested?

Quick Summary

What Works	What Doesn’t
Positive alpha over the S&P BSE 500 TRI across the 1, 2, 3, and 5-year trailing periods	Since-inception alpha is essentially flat — the portfolio has matched, not beaten, its benchmark over the full cycle
Experienced fund manager (28 years in Indian equities) with continuity since the strategy’s launch	Top 5 holdings, top 5 sectors, stock count, and market-cap composition are all undisclosed
Zero exit load — you can leave without a financial penalty at any point	Steep fee load (2.50% fixed, or 1.50% + 15% profit share above a 10% hurdle) for a strategy that hasn’t shown a durable edge over its own benchmark
Reasonable AUM (₹1,512.71 Cr) — not over-large for a multi-cap/flexi-cap mandate	Momentum has cooled sharply — CY25 at 5.45%, CY26 YTD at -4.55%, well below the strategy’s 2020-2023 run rate

Verdict: Helios India Rising PMS has delivered strong absolute returns in its stronger years and modest alpha over shorter trailing periods, but on a full-cycle, since-inception basis it has tracked its benchmark almost exactly — while charging you several multiples of what a passive alternative would cost.

Whether that’s a “hold” or a “review” depends on what you can’t currently see: what’s actually in the portfolio.

The PMS Value Framework

Before you read another word, understand the only test that matters for any PMS:

Gross Alpha > Fee = Value Added | Gross Alpha ≈ Fee = Break-Even | Gross Alpha < Fee = Value Destroyed

Where does Helios India Rising PMS sit?

On the numbers disclosed to us, the strategy’s since-inception return (19.01%) sits almost exactly on top of its own benchmark’s since-inception return (19.03%) — a gap of -0.02%.

That places the fund squarely in the break-even zone: the fee you’re paying isn’t clearly destroying value, but it isn’t clearly earning its keep either.

You’re paying an active-management premium for what has, over the full cycle, been a benchmark-matching outcome.

Table of Contents:

1. Who Should Read This
2. Who This PMS May Still Suit
3. Who Should Likely Avoid This PMS
4. What Is Helios India Rising PMS?
5. Performance Review
6. The Fee Reality
7. The Zero-Based Thinking Test
8. Decision Factor Scorecard
9. The Core Portfolio Architecture Question
10. What a Genuinely Complementary PMS Looks Like
11. Exit Considerations
12. Key Takeaways
13. FAQ
14. Our Approach

Who Should Read This

• You’re currently invested in Helios India Rising PMS and want an honest, data-first review of whether it’s still doing its job
• You’re a prospective investor evaluating this PMS against your existing mutual fund portfolio
• You hold ₹50 lakh or more in investable assets and are weighing PMS as part of a satellite allocation
• You want to understand how PMS fee structures actually eat into your returns, in rupee terms, not just percentages
• You’re building — or trying to make sense of — a core-satellite portfolio and don’t know where this fund fits

Who This PMS May Still Suit

• Investors who specifically want exposure to Dharmendra Grover’s 28 years of Indian equity judgment and are comfortable paying for that continuity
• Investors who value the zero exit load and want the flexibility to enter or exit without a lock-in penalty
• Investors with a genuinely long horizon (7-10 years+) who are prepared to sit through drawdown years like CY22 and CY26 YTD without reacting
• Investors who are willing to request full portfolio disclosure directly from the AMC before committing, and who will actually do that diligence

Who Should Likely Avoid This PMS

• Investors who already hold multiple flexi-cap or multi-cap mutual funds and cannot verify — because the AMC hasn’t disclosed holdings — whether this PMS is adding anything different
• Investors uncomfortable committing ₹50 lakh to a strategy where top holdings, sectors, and market-cap mix are marked “Undisclosed”
• Investors primarily seeking downside protection; the disclosed data doesn’t let you verify how the strategy behaved relative to its benchmark in down years
• Cost-conscious investors who haven’t first asked: would a low-cost index fund or a well-run flexi-cap mutual fund get you 90% of the way here?

What Is Helios India Rising PMS?

Key Fact	Detail
AMC	Helios Capital Asset Mgnt India Pvt Ltd
Strategy	India Rising PMS
Category	PMS – Multi Cap & Flexi Cap
Benchmark	S&P BSE 500 TRI
Inception Date	16 March 2020
Portfolio Age	6 years, 2 months (as on 31 May 2026)
Minimum Investment	₹50,00,000
AUM	₹1,512.71 Cr
Fund Manager	Dharmendra Grover (28 years in Indian equities)
SIP / STP	Available

Here’s the thing about the mandate.

Helios India Rising PMS describes itself as a long-only, multi-cap portfolio scheme that will “endeavour to generate positive alpha over its benchmark over the medium and long term.”

That’s a fair, honest promise — no PMS should promise guaranteed outperformance, and this one doesn’t.

But a promise only means something if you can check it against the data.

Over the medium term (1, 2, 3, and 5 years), it’s been kept. Over the long term — the full life of the strategy since March 2020 — it hasn’t quite been kept. Not badly broken. Just not kept.

That distinction matters, and we’ll come back to it.

Dharmendra Grover’s background is genuinely strong — SBI Mutual Fund, Tata Securities, Tata Motors, Credit Suisse Securities, and an exclusive advisory role to Helios Singapore before joining Helios AMC.

Continuity risk here is low: he has run this strategy since inception, with no evidence of a manager change disrupting the mandate.

Performance Review

Trailing Returns Vs Benchmark (as on 31 May 2026)

Period	Helios India Rising PMS	S&P BSE 500 TRI	Alpha (+/-)
1 Year	3.38%	-0.07%	+3.45%
2 Year	5.00%	4.14%	+0.86%
3 Year	15.62%	13.46%	+2.16%
5 Year	13.22%	12.29%	+0.93%
Since Inception	19.01%	19.03%	-0.02%

Calendar Year Returns (India Rising PMS)

CY20	CY21	CY22	CY23	CY24	CY25	CY26 YTD
40.70%	33.15%	-3.78%	32.04%	24.17%	5.45%	-4.55%

Now look at both tables together — that’s where the real picture is.

The trailing-return table shows the strategy beating its benchmark in every window except the longest one.

Genuinely positive alpha at 1, 2, 3, and 5 years. That’s not nothing.

But the calendar-year table tells you why the since-inception number has flattened out. CY20 and CY21 were exceptional — 40.7% and 33.15% — the post-COVID recovery rally that lifted almost every multi-cap and flexi-cap strategy in India, benchmark included. CY23 and CY24 stayed strong.

But CY25 slowed to 5.45%, and CY26 is running at -4.55% year-to-date. The edge built up in the recovery years is the edge now being given back.

Is that a market-wide style rotation, or something specific to this portfolio?

Honestly, we can’t tell you — because we don’t know what the portfolio actually holds.

Conclusion on the pattern: The underperformance at the “since inception” horizon doesn’t look like a structural failure of stock-picking.

It looks like a strong recovery-era return stream that has normalized toward the benchmark as markets matured — which is a legitimate, explainable pattern, not a red flag on its own.

What is a legitimate concern is that you’re paying an active fee for a return stream that, net of the recovery years, is now running close to — or below — its benchmark on a rolling basis.

The Fee Reality

Fee Structure

Component	Fixed Fee Plan	Variable Fee Plan
AMC Fee	2.50%	1.50%
Hurdle Rate	—	10.00%
Profit Sharing	—	15% above 10% hurdle
Exit Load (Yr. 1 / 2 / 3)	0.00% / 0.00% / 0.00%	0.00% / 0.00% / 0.00%

Notice something?

Every single calendar year from CY20 to CY24 cleared the 10% hurdle — several of them by a wide margin.

If you’re on the Variable Fee Plan, that means a 15% profit-sharing charge would have applied in most of those years, on top of the 1.50% base fee.

We can’t tell you with certainty whether the 19.01% since-inception figure already reflects that profit share or only the base fee — the disclosure doesn’t specify.

That’s a question worth putting to your relationship manager, in writing, before you make your next decision.

Fee Drag on ₹50 Lakhs: The Rupee Picture

Using the since-inception rates disclosed above, and assuming a passive index fund replicating the S&P BSE 500 TRI at a 0.15% fee:

Scenario	Return Assumed (p.a.)	Corpus After 5 Years	Corpus After 7 Years
Helios India Rising PMS (Net, at disclosed SI rate)	19.01%	₹1,19,36,782	₹1,69,06,519
Passive Index Fund tracking S&P BSE 500 TRI (Net of 0.15% fee)	18.88%	₹1,18,71,729	₹1,67,77,667
The Gap	—	₹65,053	₹1,28,851

Let’s be honest about what this shows, because it would be easy to spin it either way.

On raw rupees, the PMS edges ahead — by about ₹65,000 over 5 years and ₹1.29 lakh over 7 years, on a ₹50 lakh corpus.

That’s real, and we’re not pretending otherwise.

But look at what you paid to get there: fees running 15-20 times what the index fund charges, single-manager risk, concentration risk in a portfolio you can’t inspect, and possibly a variable cost you can’t predict in advance — all for a gap worth roughly 1% of your corpus over seven years.

The index fund doesn’t claim to be special. It just tracks the market at a fraction of the cost — and on this data, it got you within a rounding error of the same outcome.

The Zero-Based Thinking Test

Here’s the question that matters more than any chart in this article: knowing everything you now know, if you were starting fresh today with this exact ₹50 lakhs, would you sign up for this same PMS?

Not “should I stay because I’ve already committed.” Not “should I stay because switching feels like admitting a mistake.”

Just — if this money were sitting in your bank account right now, uninvested, and someone handed you this same fact sheet, would you write the cheque?

That’s the only honest way to evaluate a holding. Everything else is sunk cost talking.

You might be asking yourself: but I’ve already been invested for years — doesn’t that count for something?

It counts for the returns you’ve already earned.

It doesn’t count as a reason to keep earning future returns from the same product if a better option exists today.

The money doesn’t know how long it’s been where it is. It only cares about where it goes from here.

So flip the framing. Staying invested is not the “safe” or “default” choice — it’s a decision, and it deserves the same scrutiny as a fresh one.

If you wouldn’t invest new money into this PMS today, given a since-inception alpha of -0.02% and a portfolio you cannot inspect, that discomfort is telling you something.

And here’s the uncomfortable part: exiting isn’t a verdict on your original decision.

Markets between 2020 and 2023 rewarded almost any reasonably run equity strategy.

You made a defensible call with the information available then.

The question in front of you now is a different one, with different information.

Would you make the same call today?

Decision Factor Scorecard

Decision Factor	Rating	Analysis
Uniqueness vs. existing MF portfolio	🔴	Unanswerable — top holdings, top sectors, and stock count are marked “Undisclosed.” No way to check whether this PMS owns anything genuinely different from your existing flexi-cap/multi-cap mutual funds.
Alpha consistency across all periods	🟡	Genuinely positive alpha at 1, 2, 3, and 5-year horizons (+3.45%, +0.86%, +2.16%, +0.93%) deserves credit. But since-inception alpha is -0.02%, with the edge concentrated in CY20-21 and fading through CY25-26 — inconsistent, not absent.
Justification for PMS premium fee	🟡	Since-inception net return sits almost exactly on the benchmark, while the fee (2.50% fixed, or 1.50% plus profit share) runs several multiples above a passive alternative. Not value-destroying outright, but not clearly earned — the break-even zone.
Downside protection in market corrections	🟡	CY22 (-3.78%) and CY26 YTD (-4.55%) confirm the strategy does draw down. But no benchmark figure is disclosed for those same years, so we can’t verify whether losses were better or worse contained than the index.
Portfolio complement for MF investor	🔴	Same root problem — without sector or stock-level disclosure, you can’t establish that this PMS reaches anything your mutual funds structurally cannot. A multi-cap mandate, by definition, overlaps heavily with most flexi-cap fund universes.
Mandate purity and discipline	🟡	The mandate reads clean, but with no visible cap-wise composition or filled-in portfolio chart, whether the flexibility is actively used — or the book quietly behaves like a large-cap fund — is unverifiable.
Fund manager transparency	🟡	Dharmendra Grover’s background is fully disclosed — 28 years across SBI MF, Tata Securities, Tata Motors, Credit Suisse, and Helios Singapore advisory work. Genuine credit here. What’s missing is portfolio-level transparency into what he’s actually running today.
Investment horizon suitability	🟢	The stated objective — alpha over the medium to long term — is realistic, not oversold. Six years is a reasonable stretch to judge a multi-cap mandate against.
Market cap flexibility utilisation	🔴	Average market cap and the cap-wise composition breakdown are both undisclosed, and the composition chart carries no visible data. For a strategy built entirely on cap flexibility, this is the single biggest disclosure gap on the fact sheet.
Concentration vs. diversification balance	🔴	Total number of stocks shows as “0” / undisclosed. No basis to judge whether this is a high-conviction concentrated book or closet-diversified — a fundamental gap for a ₹50 lakh-minimum product.
AUM size and strategy capacity	🟢	₹1,512.71 Cr is reasonable for a multi-cap/flexi-cap strategy — large enough to signal investor confidence, not so large that capacity looks like an obvious risk.
Manager tenure and continuity risk	🟢	Grover has run this strategy since its March 2020 inception — over six years of continuous tenure with no evidence of transition. Continuity risk is genuinely low.
Portfolio disclosure & transparency (strategy-specific)	🔴	Top holdings, top sectors, stock count, and cap-wise composition are all undisclosed. For a premium-fee, ₹50 lakh-minimum PMS, this makes independent due diligence effectively impossible.

Summary Scorecard

Decision Factor	Rating
Uniqueness vs. existing MF portfolio	🔴
Alpha consistency across all periods	🟡
Justification for PMS premium fee	🟡
Downside protection in market corrections	🟡
Portfolio complement for MF investor	🔴
Mandate purity and discipline	🟡
Fund manager transparency	🟡
Investment horizon suitability	🟢
Market cap flexibility utilisation	🔴
Concentration vs. diversification balance	🔴
AUM size and strategy capacity	🟢
Manager tenure and continuity risk	🟢
Portfolio disclosure & transparency	🔴

The Core Portfolio Architecture Question

Here’s a way of thinking about your portfolio that has nothing to do with this specific PMS.

Your core should be the part of your portfolio you don’t have to think about — low-cost, diversified, built from index funds, flexi-cap funds, or multi-asset funds giving broad market exposure at minimal cost.

It’s not supposed to be exciting. It’s supposed to be reliable.

Your satellite is where you take selective, higher-conviction bets — PMS and AIF strategies that earn their place by doing something your core structurally cannot: a concentrated small-cap opportunity set, a genuinely differentiated sector tilt, positions a mutual fund’s diversification mandate would never allow.

The test for anything in your satellite sleeve is simple: does it complement the core, or quietly duplicate it at a much higher price?

A multi-cap/flexi-cap PMS sits in contested territory here — its investable universe overlaps heavily with what flexi-cap mutual funds already cover.

That doesn’t automatically disqualify it, but it raises the bar for what “differentiated” needs to mean before it earns a place in your satellite allocation.

What a Genuinely Complementary PMS Looks Like

If you’re evaluating any PMS — this one or another — for your satellite sleeve, look for these general markers:

• Disclosed, verifiable holdings you can actually cross-check against your existing mutual fund portfolio for overlap
• A market segment or strategy type your core mutual funds structurally cannot access — deep small-cap, special situations, sector-specific concentration, or a genuinely distinct factor tilt
• Alpha that holds up across full market cycles, not just in a rising-market window
• A fee structure that scales with delivered value, not one that’s payable regardless of outcome
• A fund manager willing to explain, in writing, why the portfolio looks the way it does — not just their personal track record, but the current book

Exit Considerations

The good news first: exit load is 0.00% in year 1, year 2, and year 3.

There is no financial penalty structure discouraging you from leaving, at any point in the holding period shown.

The part that needs more care is tax. Unlike a mutual fund, a PMS holds securities directly in your own Demat account.

That means every buy and sell the fund manager executes on your behalf is a taxable event for you — stock-level LTCG or STCG, not fund-level capital gains recognized only on your own redemption.

This makes PMS exits more paperwork-intensive than a mutual fund switch, and it’s worth planning for.

If you do decide to exit, consider a staggered approach rather than a single redemption — spreading the exit across a financial year or two can help manage the tax-loss/tax-gain timing on individual stock positions rather than triggering everything in one go.

There’s no exit-load clock forcing your hand here; the timing decision should be driven by your tax position and your replacement plan, not by any penalty structure in this product.

Key Takeaways

1. Helios India Rising PMS has delivered genuine, positive alpha over the S&P BSE 500 TRI at the 1, 2, 3, and 5-year trailing horizons.
2. Since inception (March 2020), the strategy has essentially matched its benchmark — an alpha gap of -0.02%.
3. The strongest returns (CY20, CY21) coincided with the broad post-COVID market recovery; momentum has cooled materially in CY25 and CY26 YTD.
4. Top holdings, top sectors, total stock count, and market-cap composition are all undisclosed — a significant transparency gap for a ₹50 lakh-minimum product.
5. The fee structure (2.50% fixed, or 1.50% plus 15% profit share above a 10% hurdle) is steep relative to a since-inception return that has barely cleared its own benchmark.
6. Exit load is nil across all years, giving you full flexibility to reconsider your position without penalty.
7. Fund manager continuity is strong — Dharmendra Grover has run this strategy since inception with no evidence of transition risk.
8. Without portfolio-level disclosure, you cannot verify whether this PMS complements or duplicates your existing mutual fund holdings.

FAQ

Q1: Is Helios India Rising PMS a good or bad PMS?

Neither uniformly, on the data disclosed. Real alpha over shorter trailing periods, but essentially benchmark-matching since inception, with key portfolio details undisclosed — which limits how confidently anyone can call it either way.

Q2: What are Helios India Rising PMS’s returns?

As on 31 May 2026: 3.38% (1-year), 5.00% (2-year), 15.62% (3-year), 13.22% (5-year), and 19.01% since inception (16 March 2020).

Q3: What is the Helios India Rising PMS fee structure?

A Fixed Fee plan (2.50% AMC fee) and a Variable Fee plan (1.50% AMC fee plus 15% profit share above a 10% hurdle). Exit load is nil in all years for Helios India Rising PMS.

Q4: What is Helios India Rising PMS’s AUM and minimum investment?

AUM is ₹1,512.71 Cr as on 31 May 2026; minimum investment is ₹50,00,000, in line with SEBI’s PMS ticket-size norms.

Q5: Who manages Helios India Rising PMS?

Dharmendra Grover, with 28 years of experience in Indian equities, has managed the Helios India Rising PMS strategy since its March 2020 inception.

Q6: Should a PMS review India investors trust rely only on trailing returns? No. Trailing returns can flatter a fund with a strong launch window. Since-inception performance, calendar-year consistency, and portfolio transparency all matter more than any single trailing number.

Q7: PMS vs mutual fund India — which is better for a multi-cap strategy?

For a multi-cap or flexi-cap mandate, a well-run mutual fund or index fund often delivers comparable exposure at a fraction of the cost, since the investable universe overlaps heavily. PMS earns its fee more convincingly where it accesses something mutual funds structurally cannot.

Q8: Are PMS fees worth it?

Only when net-of-fee alpha is consistent, verifiable, and the portfolio is genuinely differentiated from what a mutual fund offers. Undisclosed holdings make that assessment impossible to complete with confidence.

Q9: How do I exit a PMS?

Since holdings sit in your own Demat account, exiting triggers stock-level capital gains tax in your hands as positions are sold. A staggered exit across a financial year or two can help manage that impact.

Q10: What does PMS underperformance mean if trailing returns look positive?

Timeframe matters. A PMS can show positive alpha over 1-3 years while running flat or negative since inception, if its strongest years came early and returns have since normalized toward the benchmark — close to the pattern here.

Our Approach

We’re a process-driven wealth advisory built around a core-satellite philosophy: a low-cost, diversified core, and a satellite sleeve reserved for strategies that genuinely complement it.

On the data currently disclosed, Helios India Rising PMS doesn’t clear our bar for recommendation — not because the manager lacks credibility, but because we can’t verify differentiation or complementarity without portfolio transparency.

If you’re already invested here, we’re happy to review this PMS alongside your existing mutual fund portfolio — as your CFP, not as a product seller — to check for genuine overlap or complementarity, and help you think through what, if anything, should change.